444 related articles for article (PubMed ID: 36778600)
21. Targeted lactate dehydrogenase genes silencing in probiotic lactic acid bacteria: A possible paradigm shift in colorectal cancer treatment?
Macharia JM; Kaposztas Z; Varjas T; Budán F; Zand A; Bodnar I; Bence RL
Biomed Pharmacother; 2023 Apr; 160():114371. PubMed ID: 36758316
[TBL] [Abstract][Full Text] [Related]
22. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Long L; Xiong W; Lin F; Hou J; Chen G; Peng T; He Y; Wang R; Xu Q; Huang Y
J Exp Clin Cancer Res; 2023 May; 42(1):117. PubMed ID: 37161591
[TBL] [Abstract][Full Text] [Related]
23. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
24. Lactate in the tumour microenvironment: From immune modulation to therapy.
Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
[TBL] [Abstract][Full Text] [Related]
25. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
26. Revisiting lactate dynamics in cancer-a metabolic expertise or an alternative attempt to survive?
Mendes C; Serpa J
J Mol Med (Berl); 2020 Oct; 98(10):1397-1414. PubMed ID: 32827258
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
28. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
[TBL] [Abstract][Full Text] [Related]
30. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
31. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.
Carito V; Bonuccelli G; Martinez-Outschoorn UE; Whitaker-Menezes D; Caroleo MC; Cione E; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2012 Sep; 11(18):3403-14. PubMed ID: 22918248
[TBL] [Abstract][Full Text] [Related]
32. Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms.
Li YC; Chen CH; Chang CL; Chiang JY; Chu CH; Chen HH; Yip HK
Int J Biol Sci; 2021; 17(14):3728-3744. PubMed ID: 34671196
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Warburg Effect in Cancer: Where Do We Stand?
Barba I; Carrillo-Bosch L; Seoane J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542116
[TBL] [Abstract][Full Text] [Related]
34. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
Biomed Pharmacother; 2017 Aug; 92():1119-1127. PubMed ID: 28622713
[TBL] [Abstract][Full Text] [Related]
35. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect.
San-Millán I; Brooks GA
Carcinogenesis; 2017 Feb; 38(2):119-133. PubMed ID: 27993896
[TBL] [Abstract][Full Text] [Related]
36. Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.
Chen AN; Luo Y; Yang YH; Fu JT; Geng XM; Shi JP; Yang J
Front Immunol; 2021; 12():688910. PubMed ID: 34177945
[TBL] [Abstract][Full Text] [Related]
37. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk between glucose metabolism, lactate production and immune response modulation.
Ye L; Jiang Y; Zhang M
Cytokine Growth Factor Rev; 2022 Dec; 68():81-92. PubMed ID: 36376165
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and Colorectal Cancer.
Sedlak JC; Yilmaz ÖH; Roper J
Annu Rev Pathol; 2023 Jan; 18():467-492. PubMed ID: 36323004
[TBL] [Abstract][Full Text] [Related]
40. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
